Skip to content
Icon-linkedin Youtube
Search
Contact us
  • About EMQN
    • Organisation
    • Careers
    • News & Events
    • Sustainability statement
    • Accreditation and Quality
  • EQA Scheme Catalogue
  • About EQA Schemes
    • 2026 Registration
    • Samples Donation
    • Discounts for evolving economies
  • Our Assessors
    • How to apply
    • Assessor Vacancies
  • Resources
    • Best Practices
    • Webinars
    • Case Studies
    • Publications
  • Support
  • About EMQN
    • Organisation
    • Careers
    • News & Events
    • Sustainability statement
    • Accreditation and Quality
  • EQA Scheme Catalogue
  • About EQA Schemes
    • 2026 Registration
    • Samples Donation
    • Discounts for evolving economies
  • Our Assessors
    • How to apply
    • Assessor Vacancies
  • Resources
    • Best Practices
    • Webinars
    • Case Studies
    • Publications
  • Support
Become a member/ log in
Search
Contact us
Log in
Icon-linkedin Icon-x Youtube
  • About EMQN
    • Organisation
    • Careers
    • News & Events
    • Sustainability statement
    • Accreditation and Quality
  • EQA Scheme Catalogue
  • About EQA Schemes
    • 2026 Registration
    • Samples Donation
    • Discounts for evolving economies
  • Our Assessors
    • How to apply
    • Assessor Vacancies
  • Resources
    • Best Practices
    • Webinars
    • Case Studies
    • Publications
  • Support
  • About EMQN
    • Organisation
    • Careers
    • News & Events
    • Sustainability statement
    • Accreditation and Quality
  • EQA Scheme Catalogue
  • About EQA Schemes
    • 2026 Registration
    • Samples Donation
    • Discounts for evolving economies
  • Our Assessors
    • How to apply
    • Assessor Vacancies
  • Resources
    • Best Practices
    • Webinars
    • Case Studies
    • Publications
  • Support

Keyword: Neurogenetics

Rare Neurological Disease (RND) Gene Panel

NGS gene panel testing for Rare Neurological Diseases (Germline DNA) (including targeted panel testing/ virtual panel /clinical exome / WES / WGS)

Charcot-Marie-Tooth disease / Hereditary Neuropathy with liability for Pressure Palsies (CMT/HNPP)

PMP22 deletion/duplication testing for CMT/HNPP, this EQA has options for PMP22 targeted testing and panel testing for CMT/HNPP associated genes (Germline DNA).

EMQN Office 

Third Floor, ICE Building, 3 Exchange Quay

Salford, M5 3ED

office@emqn.org 
+44 161 757 1591

Subscribe to our newsletter

Subscribe
Contact us for more information
Contact us
Click here for more information

Subscribe to our newsletter

Subscribe
Contact us for more information
Contact us

EMQN Office

Unit 4, Enterprise House
Pencroft Way
Manchester Science Park
Manchester
M15 6SE
UK

office@emqn.org
+44 161 757 1591

Click here for more information

Terms & Conditions | Privacy Policy 

©2026 EMQN. All rights reserved.